EUVIMEDEUVIMED entdecken
Crossref

PD ‐1 Regulates the Glycolytic Pathway to Reverse Abnormal CD4 + T Cell Differentiation and Alleviate Hashimoto's Thyroiditis

Xiao Jiang, Tao Luo, Xinyu Zhao, Pengqian Li, Xiaotong Gu, Chuchu Wan, Xingjie Xie, Haixia Liu

Immunology · 2025

DOI: 10.1111/imm.13953 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology, 2025. Verfasst von Xiao Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Metabolism Department, The Second Affiliated Hospital of Dalian Medical University, Dalian, China. Hauptthemen laut MEDLINE: Glycolysis, Programmed Cell Death 1 Receptor, Hashimoto Disease, Cell Differentiation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: "Xingliao Talent Plan" of Liaoning, China, Dalian Science and Technology Innovation Fund, the Dalian Science and Technology Bureau, "1+X" program for Clinical Competency enhancement-Clinical Research Incubation Project, The Second Hospital of Dalian Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hashimoto's thyroiditis (HT) is a prevalent autoimmune disease lacking a specific cure. This study endeavours to explore the role of PD‐1 in modulating glycolysis during CD4 + T cell differentiation in HT. The lactate and glucose content in different groups was assessed using lactate and glucose assay kits. The tissue and cellular expression of HK2 and LDHA proteins was examined through Western blot analysis, while Glut1 expression and the ratio of Treg/Th17 cells were analysed using flow cytometry. The glycolysis levels in the HT group were higher than those in the control group. Additionally, the HTE group exhibited a decreased proportion of CD4 + CD25 + Tregs and an increased proportion of CD4 + TH17 cells compared to the healthy control group. Following the addition of PD‐1 inhibitors to the activated group, both the glycolysis levels and CD4 + T cell differentiation showed improvement. PD‐1 can regulate aberrant CD4 + T cell differentiation by modulating the glycolytic pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycolysisProgrammed Cell Death 1 ReceptorHashimoto DiseaseCell DifferentiationCD4-Positive T-LymphocytesHumansFemaleMaleAdultMiddle AgedT-Lymphocytes, RegulatoryTh17 CellsLymphocyte ActivationHexokinaseGlucose Transporter Type 1

Stichwörter der Autor:innen

CD4+ T cellsHashimoto's thyroiditisPD‐1Th17/Treg imbalanceglycolysis

Substanzen

Programmed Cell Death 1 ReceptorPDCD1 protein, humanHexokinaseGlucose Transporter Type 1

Autor:innen und Institutionen

  • Endocrinology and Metabolism Department, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Graduate School Department, Dalian Medical University, Dalian, China.

Förderung

  • "Xingliao Talent Plan" of Liaoning, China
  • Dalian Science and Technology Innovation Fund, the Dalian Science and Technology Bureau
  • "1+X" program for Clinical Competency enhancement-Clinical Research Incubation Project, The Second Hospital of Dalian Medical University
  • Dalian Science and Technology Innovation Fund

Zitieren

APA

Jiang, X., Luo, T., Zhao, X., Li, P., Gu, X., Wan, C., Xie, X., & Liu, H. (2025). PD ‐1 Regulates the Glycolytic Pathway to Reverse Abnormal CD4 + T Cell Differentiation and Alleviate Hashimoto's Thyroiditis. Immunology. https://doi.org/10.1111/imm.13953

Vancouver

Jiang X, Luo T, Zhao X, Li P, Gu X, Wan C, et al. PD ‐1 Regulates the Glycolytic Pathway to Reverse Abnormal CD4 + T Cell Differentiation and Alleviate Hashimoto's Thyroiditis. Immunology. 2025. doi:10.1111/imm.13953

BibTeX
@article{Jiang2025,
  author = {Jiang, Xiao and Luo, Tao and Zhao, Xinyu and Li, Pengqian and Gu, Xiaotong and Wan, Chuchu and Xie, Xingjie and Liu, Haixia},
  title = {PD ‐1 Regulates the Glycolytic Pathway to Reverse Abnormal CD4 + T Cell Differentiation and Alleviate Hashimoto's Thyroiditis},
  journal = {Immunology},
  year = {2025},
  doi = {10.1111/imm.13953}
}
Kostenlos starten →